The agreement that stemmed from patients who used the popular blood thinner Xarelto caps one of the more high-profile instances of product liability litigation facing the pharmaceutical industry in recent years.
from Kaiser Health News https://ift.tt/2TZAOyA
Rose
0 comments:
Post a Comment